Evozyne
Jeff Mayer is a skilled research scientist with extensive experience in oncology research and molecular biology. Currently serving as Research Scientist II at Evozyne since March 2021, Jeff previously held positions as Research Scientist I at the same company, and Scientist I at AbbVie, where contributions included designing experimental protocols and optimizing cell models. Prior experience at Regeneron Pharmaceuticals involved advanced molecular cloning and mouse model characterization. Jeff holds a Master of Science in Biotechnology from Northwestern University and a Bachelor of Science in Cell/Cellular and Molecular Biology from the University of Illinois Urbana-Champaign.
Evozyne
1 followers
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.